Related Experiment Videos
Traps to catch unwary oncogenes
1Biochemistry of the Cell Nucleus Laboratory, Imperial Cancer Research Fund, London, UK. a.hueber@icrf.icnet.uk
Abstract:
The MYC proto-oncogene has long been implicated in the control of normal cell growth and its deregulation is associated with the development of neoplasia. The MYC protein has a well-established role as a component of signal-transduction pathways promoting both proliferation and apoptosis. Because signalling pathways that drive cell death and cell proliferation are so tightly coupled, a synergy between genetic lesions leading to suppression of cell death and those promoting cell proliferation is observed during carcinogenesis. We discuss such synergy with respect to the cooperating oncogenes MYC, RAS and BCL2.
Insights
The MYC proto-oncogene regulates cell growth and its abnormal activity is linked to cancer. MYC, RAS, and BCL2 oncogenes work together to promote cell proliferation and block cell death during cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The MYC proto-oncogene is crucial for normal cell growth.
- MYC deregulation is a key factor in neoplasia development.
- MYC protein influences cell proliferation and apoptosis signaling pathways.
Purpose of the Study:
- To discuss the synergistic roles of cooperating oncogenes in carcinogenesis.
- To explore the interplay between MYC, RAS, and BCL2 in cancer development.
Main Methods:
- Literature review and discussion of existing research on MYC, RAS, and BCL2.
- Analysis of signaling pathways involved in cell proliferation and apoptosis.
- Examination of genetic lesions contributing to carcinogenesis.
Main Results:
- Genetic lesions suppressing cell death and promoting cell proliferation exhibit synergy during carcinogenesis.
- Cooperating oncogenes like MYC, RAS, and BCL2 contribute to this synergistic effect.
- The tightly coupled nature of cell death and proliferation pathways facilitates cancer progression.
Conclusions:
- The interplay between MYC, RAS, and BCL2 highlights a critical mechanism in cancer development.
- Understanding this synergy is vital for developing targeted cancer therapies.
- Targeting cooperating oncogenes offers a potential strategy for cancer treatment.